238 related articles for article (PubMed ID: 31326731)
21. Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary.
Gershenson DM
Gynecol Oncol; 2012 Jun; 125(3):515-7. PubMed ID: 22426486
[No Abstract] [Full Text] [Related]
22. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
23. Ovarian cancer during pregnancy.
Gezginç K; Karataylı R; Yazıcı F; Acar A; Celik C; Capar M
Int J Gynaecol Obstet; 2011 Nov; 115(2):140-3. PubMed ID: 21872237
[TBL] [Abstract][Full Text] [Related]
24. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
[TBL] [Abstract][Full Text] [Related]
25. Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
Sköld C; Koliadi A; Enblad G; Stålberg K; Glimelius I
Int J Cancer; 2022 Mar; 150(5):773-781. PubMed ID: 34648676
[TBL] [Abstract][Full Text] [Related]
26. Ovarian sex cord stromal tumours in children and young girls - a more than two decade clinicopathological experience in a developing country, Pakistan.
Haroon S; Idrees R; Zia A; Memon A; Fatima S; Kayani N
Asian Pac J Cancer Prev; 2014; 15(3):1351-5. PubMed ID: 24606464
[TBL] [Abstract][Full Text] [Related]
27. Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects.
Boussios S; Moschetta M; Zarkavelis G; Papadaki A; Kefas A; Tatsi K
Crit Rev Oncol Hematol; 2017 Dec; 120():43-51. PubMed ID: 29198337
[TBL] [Abstract][Full Text] [Related]
28. Incidence and treatment outcomes of ovarian sarcoma compared to epithelial ovarian cancer from the national cancer registry.
Ha HI; Cho SH; Lim J; Lee YJ; Yoo CW; Won YJ; Lim MC
Gynecol Oncol; 2021 Dec; 163(3):506-510. PubMed ID: 34602286
[TBL] [Abstract][Full Text] [Related]
29. The multidisciplinary approach to ovarian tumours in children and adolescents.
van Heerden J; Tjalma WA
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():103-110. PubMed ID: 31683108
[TBL] [Abstract][Full Text] [Related]
30. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Colombo N; Peiretti M; Garbi A; Carinelli S; Marini C; Sessa C;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii20-6. PubMed ID: 22997450
[No Abstract] [Full Text] [Related]
31. Trends in the incidence of ovarian cancer and borderline tumours in Norway, 1954-1993.
Bjørge T; Engeland A; Hansen S; Tropé CG
Int J Cancer; 1997 May; 71(5):780-6. PubMed ID: 9180146
[TBL] [Abstract][Full Text] [Related]
32. The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland.
Pauniaho SL; Salonen J; Helminen M; Vettenranta K; Heikinheimo M; Heikinheimo O
Cancer Causes Control; 2012 Dec; 23(12):1921-7. PubMed ID: 23011538
[TBL] [Abstract][Full Text] [Related]
33. Histological pattern of ovarian neoplasma.
Ahmad Z; Kayani N; Hasan SH; Muzaffar S; Gill MS
J Pak Med Assoc; 2000 Dec; 50(12):416-9. PubMed ID: 11191442
[TBL] [Abstract][Full Text] [Related]
34. Ovarian tumours in childhood and adolescence.
Hatzipantelis ES; Dinas K
Eur J Gynaecol Oncol; 2010; 31(6):616-20. PubMed ID: 21319502
[TBL] [Abstract][Full Text] [Related]
35. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
[TBL] [Abstract][Full Text] [Related]
36. Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
Ray-Coquard I; Weber B; Lotz JP; Tournigand C; Provencal J; Mayeur D; Treilleux I; Paraiso D; Duvillard P; Pujade-Lauraine E;
Gynecol Oncol; 2010 Oct; 119(1):53-9. PubMed ID: 20580063
[TBL] [Abstract][Full Text] [Related]
37. Differential expression of E-cadherin and catenins in ovarian sex cord stromal tumours.
Stavrinou S; Clark A; Irving J; Lee CH; Oliva E; Young R; Sriraksa R; Magdy N; Van Noorden S; McCluggage WG; El-Bahrawy M
Histopathology; 2016 Aug; 69(2):298-306. PubMed ID: 27097978
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
Zhang C; Xi X
Oncol Res Treat; 2023; 46(11):476-492. PubMed ID: 37857263
[TBL] [Abstract][Full Text] [Related]
39. On the histogenesis of mixed germ cell-sex cord stromal tumour of the gonads.
Roth LM; Cheng L
J Clin Pathol; 2017 Mar; 70(3):222-227. PubMed ID: 27458149
[TBL] [Abstract][Full Text] [Related]
40. Lymph-node metastasis in stage I and II sex cord stromal and malignant germ cell tumours of the ovary: a systematic review.
Kleppe M; Amkreutz LC; Van Gorp T; Slangen BF; Kruse AJ; Kruitwagen RF
Gynecol Oncol; 2014 Apr; 133(1):124-7. PubMed ID: 24440833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
